Abstract:Antiangiogenesis therapy has become a hot field in cancer research. Blood vessels of tumor carry specific markers that are usually related to angiogenesis. Study of these heterogeneous molecules in different tumor vessels may be beneficial for promoting antiangiogenic therapy. In this study, we established an in vitro co-culture model of human umbilical vein endothelial cells (HUVECs) and gastric adenocarcinoma cell line SGC7901, screened the peptides binding specifically to the HUVECs co-cultured with gastric cancer cells (Co-HUVECs) using phage display peptides library, and studied the affinity of these peptides to gastric cancer vascular endothelial cells. After four rounds of panning, there was an obvious enrichment for the phages specifically binding to the Co-HUVECs, and the output/input ratio of Co-HUVECs increased about 590-fold (from 0.95×10−7 to 561.25×10−7). Five phage clones (M6, M3, M9, IN12, IN11), which could strongly bind to Co-HUVECs instead of wild-type HUVECs, were characterized by ELISA. In vitro cellular binding assay showed that phage IN11 preferably bound to Co-HUVECs rather than control HUVECs, and the number of the phage IN11 recovered from Co-HUVECs was 5.7- and 16.9-folds, respectively, as much as those from control HUVECs and GES cells. Immunocytochemical and immunohistochemical staining confirmed that phage IN11 could specifically bind to Co-HUVECs as well as vascular endothelial cells in gastric cancer tissue sections. Competitive and inhibitory assay revealed the synthetic peptide GEBP11 (CTKNSYLMC) displayed on phage IN11 could competitively inhibit binding of the phage IN11 to Co-HUVECs. Immunofluorescence microscopy showed that the fluorescence-labeled peptide GEBP11 was located at the membrane and perinuclear cytoplasm of Co-HUVECs. Meanwhile, GEBP11 was found to be able to target the gastric cancer vascular endothelial cells. Therefore, GEBP11 may be a potential candidate for targeted drug delivery in antivascular therapy and diagnosis of gastric cancer.

Identification of a novel peptide from Coina intestinalis with potent antiangiogenetic activity

Cs5931, A Novel Polypeptide In Ciona Savignyi, Represses Angiogenesis Via Inhibiting Vascular Endothelial Growth Factor (Vegf) And Matrix Metalloproteinases (Mmps)

Inhibition of Angiogenesis by a Novel Small Peptide Consisting of the Active Fragments of Platelet Factor-4 and Vasostatin

Novel Peptide from the Hydrolysate of Hybrid Sturgeon<i> (Acipenseridae)</i> Spinal Cord: Isolation, Identification, and Anti- proliferative Effects in Human Cervix Cancer Cells

Isolation,Characterization and Biological Activity of A Novel Peptide from Sika(Cervus nippon Temminck) Antler

Study of screening, transport pathway, and vasodilation mechanisms on angiotensin-I converting enzyme inhibitory peptide from Ulva prolifera proteins

Identification of Novel Nonapeptides from Sipunculus nudus L. and Comparing Its ACEI Activities Mechanism by Molecular Docking

In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.

A novel polypeptide from shark cartilage with potent anti-angiogenic activity.

Identification of a Novel ACE-inhibitory Peptide from Casein and Evaluation of the Inhibitory Mechanisms.

[Inhibition of tumor growth by a peptide fusion protein binding to vascular endothelial growth factor receptor Flt-1]

CPU-12, a novel synthesized oxazolo[5,4- d ]pyrimidine derivative, showed superior anti-angiogenic activity

The antibacterial and antitumor function of a novel bio-active peptide Catesbeianin-1a of Rana catesbeiana

PE, a New Sulfated Saponin from Sea Cucumber, Exhibits Anti-Angiogenic and Anti-Tumor Activities in Vitro and in Vivo.

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

A Novel Peptide Specifically Binding to VEGF Receptor Suppresses Angiogenesis in Vitro and in Vivo

Preparation and Antitumor Activity of CS5931, A Novel Polypeptide from Sea Squirt Ciona Savignyi.

A Hybrid Peptide P18 Derived from Cecropin-A and Magainin-2 Inhibits Angiogenesis in Vitro

A Novel Antiangiogenic Peptide Derived From Hepatocyte Growth Factor Inhibits Neovascularization In Vitro And In Vivo

Isolation and Antiproliferation of Tumor Cells by a Novel Peptide (TC22) from the Beetle Tribolium Castaneum.

A Novel Peptide From Human Apolipoprotein(A) Inhibits Angiogenesis And Tumor Growth By Targeting C-Src Phosphorylation In Vegf-Induced Human Umbilical Endothelial Cells